-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
AEON Biopharma, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate for 2022.
- AEON Biopharma, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $25K, unchanged year-over-year.
Depreciation, Depletion and Amortization, Annual (USD)